Related Experiment Video
Updated: Jul 27, 2026
23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Therapy of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis
Barbara J Seaworth1, David E Griffith1
1Heartland National TB Center, University of Texas Health Science Center-UT Health Northeast, San Antonio, TX 78223.
Microbiology Spectrum
|April 1, 2017
Summary
Multidrug-resistant tuberculosis (MDR-TB) is a growing global threat, with limited treatment success despite new drug options. Key challenges include managing toxicity and improving patient outcomes for drug-resistant strains.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- The global epidemic of multidrug-resistant tuberculosis (MDR-TB) is larger than previously estimated, with over 580,000 new cases in 2015.
- Extensively drug-resistant tuberculosis (XDR-TB) comprises nearly 10% of MDR-TB cases, with significant burdens in India, China, and Russia.
- Despite advances in molecular diagnostics and expanded treatment options, only 20% of MDR-TB cases are currently receiving treatment.
Purpose of the Study:
- To review the current landscape of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB).
- To discuss updated World Health Organization (WHO) treatment guidelines and novel therapeutic strategies.
- To highlight ongoing challenges in MDR-TB management, including treatment toxicity, duration, and patient outcomes.
Main Methods:
- Review of recent global MDR-TB and XDR-TB statistics.
- Analysis of updated WHO treatment guidelines for MDR-TB.
- Discussion of current and emerging drug classifications and treatment regimens.
Main Results:
- MDR-TB and XDR-TB present significant global health challenges, particularly in specific high-burden countries.
- Newer drug classifications include key second-line agents like linezolid and clofazimine, with bedaquiline and delamanid options.
- Despite improved treatment options, outcomes for MDR-TB and especially XDR-TB remain significantly worse than for drug-susceptible tuberculosis.
Conclusions:
- Effective management of MDR-TB requires addressing treatment toxicity and optimizing long-duration regimens.
- Preventing transmission and identifying/managing infected contacts are crucial for future control efforts.
- Continued research and improved global strategies are essential to combat the growing threat of drug-resistant tuberculosis.
Related Concept Videos
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...